Propranolol Hydrochloride

CAS 318-98-9 8 current records 12 historicalSmall Molecule

Who holds supplier records for Propranolol Hydrochloride? 8 organisations hold a current record for Propranolol Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 12 organisations have only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), United States (2) and Italy (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Propranolol Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/propranolol-hydrochloride

Reading the evidence

  • 8 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    5 of the 8 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Propranolol Hydrochloride expires 16 Oct 2028. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (8)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Propranolol Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Propranolol Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Propranolol Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
IPCA LABORATORIES LIMITED MumbaiIN
CEP 2002-026 - Rev 07
Propranolol hydrochloride
Feb 2026—
MANKIND PHARMA LIMITED New DelhiIN
CEP 2021-104 - Rev 01
Propranolol hydrochloride
Jun 2025—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (12)

Organisations whose Type II DMFs for Propranolol Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 12 historical records
  • India · Inactive DMF 33222 · filed Oct 2018
  • Cyanamid UK
    United Kingdom · Inactive DMF 9312 · filed Aug 1991
  • BOEHRINGER KNOLL LTD
    Inactive DMF 8309 · filed Nov 1989
  • India · Inactive DMF 5937 · filed May 1985
  • UNIQUE PHARMACEUTICAL LABORATORIES A DIV OF JB CHEMICALS AND PHARMACEUTICALS LTD
    Inactive DMF 5325 · filed Mar 1984
  • KLINGE PHARMA CO
    Inactive DMF 5079 · filed Aug 1983
  • OMNICHEM NV
    Inactive DMF 4896 · filed May 1983
  • KNOLL AG LUDWIGSHAFEN
    Inactive DMF 4830 · filed Jan 1983
  • LEK PHARMACEUTICAL AND CHEMICAL CO DD
    Inactive DMF 4458 · filed Feb 1982
  • SIFAVITOR SRL
    Inactive DMF 4288 · filed Oct 1981
  • INDUSTRIA CHEMICA PRODOTTI FRANCIS SPA
    Inactive DMF 3663 · filed Nov 1979
  • AYERST LABORATORIES INC DIV AMERICAN HOME PRODUCTS CORP
    Inactive DMF 2009 · filed Oct 1972

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (83 listed products contain Propranolol Hydrochloride). The latest listed patent expires 16 Oct 2028. The latest listed exclusivity runs to 15 Feb 2027. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Propranolol hydrochloride is a non-selective beta blocker used in the treatment of hypertension and various cardiovascular disorders. It is also indicated for anxiety, migraine prophylaxis, and certain types of tremors.

Chemical identity

IUPAC name
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
Canonical SMILES
CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O
InChIKey
AQHHHDLHHXJYJD-UHFFFAOYSA-N
Synonyms
Inderal API, propranolol, Propanolol, beta-Propranolol, Betalong, Euprovasin, Proprasylyt, Reducor, Propanalol, Anapriline, propranololo, dl-propranolol

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
beta-Adrenergic Blocker
Mechanism of action
Adrenergic beta-Antagonists

Therapeutic areas

Cardiovascular DiseasesAnxiety DisordersThyroid Disorders

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Propranolol Hydrochloride?

8 organisations hold an active US FDA Type II Drug Master File or a CEP for Propranolol Hydrochloride: Ipca Laboratories Limited (India), Mankind Pharma Limited (India), ALIVUS LIFE SCIENCES LTD (India), COSMA SPA (Italy), Macleods Pharmaceuticals Ltd. (India), RAKS PHARMA PVT LTD (India), SIMS SRL (United States) and W R GRACE AND CO -CONN (United States). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Propranolol Hydrochloride Drug Master Files are active?

Ipca Laboratories Limited (DMF 15849), Mankind Pharma Limited (DMF 35635), ALIVUS LIFE SCIENCES LTD (DMF 39782), COSMA SPA (DMF 4104), Macleods Pharmaceuticals Ltd. (DMF 39752), RAKS PHARMA PVT LTD (DMF 42398), SIMS SRL (DMF 5139) and W R GRACE AND CO -CONN (DMF 5861). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Propranolol Hydrochloride records mean?

12 organisations have only inactive Type II DMFs for Propranolol Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Propranolol Hydrochloride have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Propranolol Hydrochloride on the EDQM register, including IPCA LABORATORIES LIMITED Mumbai (IN) and MANKIND PHARMA LIMITED New Delhi (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Propranolol Hydrochloride?

Yes. The latest patent listed for an approved US product containing Propranolol Hydrochloride expires 16 Oct 2028, across 83 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Propranolol Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Propranolol Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.